Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 10Breast Neoplasms 9Colonic Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Adenomatous Polyposis Coli 4Sarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Paranasal Sinus Neoplasms 2Neoplasms 2Mouth Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gliosarcoma 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Stomatitis 1Smoldering Multiple Myeloma 1Smoking 1Recurrence 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Precancerous Conditions 1

Interventions

Tobacco Use Cessation Devices 2zileuton 1olaparib 1Vitamin B 12 1Varenicline 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cetuximab 1Celecoxib 1Budesonide 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Smoking × Celecoxib × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡